Sarepta Therapeutics (NASDAQ: SRPT) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Momentum Movers Trader Talk

Sarepta (SRPT) Wins Key PTO Decision on Composition of Matter Patents - OppenheimerSeptember 20, 2016 1:18 PM Sarepta Therapeutic (SRPT) PT Raised to $66 at WedbushSeptember 20, 2016 7:21 AM RBC Capital Upgrades Sarepta (SRPT) to Outperform; Becomes Attractive M&A TargetSeptember 19, 2016 1:52 PM Sarepta Therapeutic (SRPT) PT Raised to $81 at Needham & CompanySeptember 19, 2016 1:37 PM Leerink Partners Upgrades Sarepta Therapeutic (SRPT) to Market PerformSeptember 19, 2016 1:29 PM Sarepta (SRPT) PT Raised to $76 at Oppenheimer Amid Eteplirsen ApprovalSeptember 19, 2016 1:08 PM Sarepta Therapeutics (SRPT) Shorts Squeezed After Eteplirsen Receives FDA ApprovalSeptember 19, 2016 11:27 AM Piper Jaffray Upgrades Sarepta Therapeutic (SRPT) to OverweightSeptember 19, 2016 10:58 AM Janney Montgomery Scott Upgrades Sarepta Therapeutic (SRPT) to BuySeptember 19, 2016 10:41 AM Sarepta Therapeutic (SRPT) Label More Inclusive Than Anticipated - OppenheimerSeptember 19, 2016 10:40 AM William Blair Upgrades Sarepta Therapeutic (SRPT) to OutperformSeptember 19, 2016 10:35 AM Sarepta Therapeutics (SRPT) Pares Gains Following FDA ApprovalSeptember 19, 2016 10:14 AM Sarepta (SRPT) calls active after FDA approves eteplirsen September 19, 2016 10:03 AM Sarepta Therapeutics (SRPT) Shares Resume Trading; Now Up 82% on FDA Eteplirsen ApprovalSeptember 19, 2016 9:59 AM FDA Approves Sarepta Therapeutics' (SRPT) EteplirsenSeptember 19, 2016 9:52 AM Sarepta Therapeutics (SRPT) Granted FDA Accelerated Approval for EteplirsenSeptember 19, 2016 9:51 AM Sarepta Therapeutics (SRPT) Halted on LUDPSeptember 19, 2016 9:51 AM